Literature DB >> 11869048

ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types.

Carla J Greenbaum1, Lakshmi K Gaur, Janelle A Noble.   

Abstract

The HLA haplotype DQA1*0102/DQB1*0602 reportely confers protection from type 1 diabetes. DQA1*0102/DQB1*0602 is present in more than 7% of ICA positive relatives screened as part of the Diabetes Prevention Trial--type 1. The presence of autoantibodies in these subjects suggests that the mechanism that protects DQB1*0602 subjects from diabetes occurs after the disease process has been initiated. However, as previously suggested, the method used to type the DQB1*0602 alleles may have lacked the sensitivity to identify alleles similar, but not identical, to DQB1*0602. In addition unusual extended haplotypes may be presented that could help account for the presence of diabetes autoantibodies. We therefore sequenced and performed extended haplotyping on samples from ICA+ relatives with DQA1*0102/DQB1*0602. In this group, sequencing confirmed DQB1*0602 in 149/150, and 152/165 have the common DRB1*1501-DQB1*0602 haplotype. Thus, high resolution typing of class II alleles either by PCR-based oligotyping or nucleotide sequencing fail to indicate any unusual genetic characteristics about these antibody-positive relatives, of which few are expected to progress to clinical disease. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869048     DOI: 10.1006/jaut.2001.0562

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  3 in total

1.  High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes.

Authors:  C J Greenbaum; G Eisenbarth; M Atkinson; L Yu; S Babu; D Schatz; A Zeidler; T Orban; C Wasserfall; D Cuthbertson; J Krischer
Journal:  Diabetologia       Date:  2004-12-16       Impact factor: 10.122

2.  Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients.

Authors:  Neihenuo Chuzho; Neeraj Kumar; Neetu Mishra; Nikhil Tandon; Uma Kanga; Gurvinder Kaur; Paras Singh; Gunja Mishra; Shreya Sharma; Narinder K Mehra
Journal:  J Diabetes Res       Date:  2021-12-27       Impact factor: 4.011

3.  Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis.

Authors:  Sanja Glisic; Parthav Jailwala
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.